Theravent Advanced Nightly Snore Therapy is an FDA-cleared Expiratory Positive Airway Pressure (EPAP) therapy designed to reduce or eliminate snoring. Since 2012, Theravent regular strength has surpassed over 1 million quiet nights of sleep for snorers and their bed partners, according to the company. This August, the company will release Theravent LITE and Theravent MAX.

“Everyone deserves a quiet night of sleep without the burden of snoring, and we will continue to do our best to help make this a reality,” says Theravent CEO Matt Williams, in a release. “The addition of Theravent LITE and Theravent MAX enables us to provide snoring solutions for all types of primary snoring.”

Theravent LITE has half the resistance level of Theravent REGULAR. Theravent LITE was designed for light to moderate snorers, and for those who have difficulty with nasal airway resistance.

Theravent MAX has double the resistance level of Theravent REGULAR, designed to tackle heavier snoring. In clinical trials, Theravent MAX showed a 73% reduction in snoring versus a 22% reduction by nasal strips. Additionally, 89% of bed partners reported that Theravent MAX reduced their partners’ loud snoring significantly.

To celebrate the launch of the new snoring products, is offering 10% off pre-orders of Theravent LITE and MAX, along with free shipping for the month of August.

“I’m extremely proud of all the efforts made by the Theravent team to bring these new products to market and offer new solutions for so many snorers and their bed partners,” Williams says. “Lack of sleep can cause many health problems and avoidable frustration. As a snorer myself, I fully understand the need for an affordable, comfortable, and easy-to-use snoring solution that actually works.”